Tiletamine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11549 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 38 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | insomnia (disease) | KG + DL |
| 2 | sleep disorder, initiating and maintaining sleep | KG + DL |
| 3 | anxiety | KG + DL |
| 4 | anxiety disorder | KG + DL |
| 5 | agoraphobia | KG + DL |
| 6 | benign paroxysmal torticollis of infancy | KG + DL |
| 7 | neurocirculatory asthenia | KG + DL |
| 8 | acute encephalopathy with biphasic seizures and late reduced diffusion | KG + DL |
| 9 | irritable bowel syndrome | KG + DL |
| 10 | dysthymic disorder | KG + DL |
| 11 | juvenile onset Parkinson disease 19A | KG + DL |
| 12 | enterocolitis (disease) | KG + DL |
| 13 | mesial temporal lobe epilepsy with hippocampal sclerosis | KG + DL |
| 14 | inherited prion disease | KG + DL |
| 15 | early myoclonic encephalopathy | KG + DL |
| 16 | myoclonus, familial | KG + DL |
| 17 | myositis fibrosa | KG + DL |
| 18 | idiopathic granulomatous myositis | KG + DL |
| 19 | acute intermittent porphyria | KG + DL |
| 20 | mitochondrial membrane transport disorder | KG + DL |
| 21 | manic bipolar affective disorder | KG + DL |
| 22 | inclusion body myositis | KG + DL |
| 23 | tendinitis | KG + DL |
| 24 | channelopathy-associated congenital insensitivity to pain, autosomal recessive | KG + DL |
| 25 | major affective disorder | KG + DL |
| 26 | fibromyalgia | KG + DL |
| 27 | atypical juvenile parkinsonism | KG + DL |
| 28 | myofascial pain syndrome | KG + DL |
| 29 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 30 | autonomic nervous system disease | KG + DL |
| 31 | osteoarthritis | KG + DL |
| 32 | alcohol withdrawal delirium | KG + DL |
| 33 | hereditary late onset Parkinson disease | KG + DL |
| 34 | rheumatoid arthritis | KG + DL |
| 35 | alcohol withdrawal | KG + DL |
| 36 | vitamin B12-responsive methylmalonic acidemia | KG + DL |
| 37 | headache disorder | KG + DL |
| 38 | common cold | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.